Book HER2 FISH Test in Saudi Arabia | Lahalak Medical Platform

Determine the most effective targeted therapy for breast and gastric cancer through precise HER2 gene amplification testing using FISH technology, ensuring a personalized treatment plan for better clinical outcomes and recovery.

Scientific name: HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH)

An advanced molecular cytogenetic technique used to detect HER2 gene amplification in tumor specimens, guiding clinicians to select targeted therapies for breast and gastric cancers based on genetic profiles.

HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH) - Precision Diagnosis for Cancer Therapy
Service type Molecular Cytogenetic Test
Duration 30-45 minutes for sampling
Fasting Fasting is not required

Included Services

  • Laboratory tissue sample analysis
  • Detailed genetic result report
  • Technical consultation for results

Medical Service Information

Importance of the Test

  • Determining eligibility for targeted therapies like Herceptin
  • Accurate diagnosis of HER2-positive breast cancer
  • Precise genetic evaluation of gastric cancer cases

Target Groups

  • Newly diagnosed breast cancer patients
  • Patients with advanced gastric cancer
  • Cases requiring tumor re-evaluation post-initial therapy

Procedure Process

  • Using fluorescent dyes to bind to specific genes
  • Examining samples under a high-resolution specialized microscope
  • Comparing HER2 gene copy numbers with internal cell references

Conditions & Notices

  • Previous pathology report required
  • Provide tissue block if from an external laboratory

Medical services you might also like